Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-13-006256
Filing Date
2013-05-16
Accepted
2013-05-16 17:40:17
Documents
1
Period of Report
2013-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5240
  Complete submission text file 0001437749-13-006256.txt   6700
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Issuer) CIK: 0001003642 (see all company filings)

EIN.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address UCSF BIOPHARMACEUTICAL SCIENCES 533 PARNASSUS AVENUE, ROOM U68 SAN FRANCISCO CA 94143
Business Address
BENET LESLIE Z (Reporting) CIK: 0001245186 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34263 | Film No.: 13852592